JP2022541572A - 創傷治癒のためのｙａｐ阻害 - Google Patents

創傷治癒のためのｙａｐ阻害 Download PDF

Info

Publication number
JP2022541572A
JP2022541572A JP2022503590A JP2022503590A JP2022541572A JP 2022541572 A JP2022541572 A JP 2022541572A JP 2022503590 A JP2022503590 A JP 2022503590A JP 2022503590 A JP2022503590 A JP 2022503590A JP 2022541572 A JP2022541572 A JP 2022541572A
Authority
JP
Japan
Prior art keywords
enf
wound
skin
days
wounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022503590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541572A5 (enExample
Inventor
シャミック・マシャラック
ヘザー・エリザベス・デジャルダン－パーク
ミミ・ボレッリ
マイケル・フランシス・ダビット
マイケル・ティー・ロンゲーカー
Original Assignee
ザ ボード オブ トラスティス オブ ザ リーランド スタンフォード ジュニア ユニヴァーシティー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ ボード オブ トラスティス オブ ザ リーランド スタンフォード ジュニア ユニヴァーシティー filed Critical ザ ボード オブ トラスティス オブ ザ リーランド スタンフォード ジュニア ユニヴァーシティー
Publication of JP2022541572A publication Critical patent/JP2022541572A/ja
Publication of JP2022541572A5 publication Critical patent/JP2022541572A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2022503590A 2019-07-26 2020-07-24 創傷治癒のためのｙａｐ阻害 Pending JP2022541572A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962879369P 2019-07-26 2019-07-26
US62/879,369 2019-07-26
PCT/US2020/043420 WO2021021607A2 (en) 2019-07-26 2020-07-24 Yap inhibition for wound healing

Publications (2)

Publication Number Publication Date
JP2022541572A true JP2022541572A (ja) 2022-09-26
JP2022541572A5 JP2022541572A5 (enExample) 2024-10-15

Family

ID=74229013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022503590A Pending JP2022541572A (ja) 2019-07-26 2020-07-24 創傷治癒のためのｙａｐ阻害

Country Status (10)

Country Link
US (1) US20220313658A1 (enExample)
EP (1) EP4003334A4 (enExample)
JP (1) JP2022541572A (enExample)
KR (1) KR20220041154A (enExample)
CN (1) CN114401718A (enExample)
AU (1) AU2020320171B2 (enExample)
BR (1) BR112022001196A2 (enExample)
CA (1) CA3144185A1 (enExample)
IL (1) IL289923A (enExample)
WO (1) WO2021021607A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102550631B1 (ko) * 2021-03-16 2023-07-03 (주)파인헬스케어 인공지능을 이용한 욕창 단계 평가 및 치료 추천을 제공하는 장치 및 방법
CA3220398A1 (en) * 2021-07-30 2023-02-02 Geoffrey Gurtner Mechanotransduction disruption mediation in skin grafting methods and compositions for use in practicing the same
US20240366565A1 (en) * 2021-09-09 2024-11-07 The Board Of Trustees Of The Leland Stanford Junior University Use of Verteporfin to Modulate Wound Healing After an Ocular Surgical Procedure or Ocular Injury
CN114288474A (zh) * 2021-12-27 2022-04-08 湖北中部医疗科技有限公司 一种促毛囊再生用真皮层、人工皮肤及其制备方法
EP4514393A4 (en) * 2022-04-28 2026-04-01 Univ Leland Stanford Junior PIEZO-ELECTRIC INHIBITION FOR Wound Healing
CN116694089B (zh) * 2022-09-19 2024-03-26 广州贝奥吉因生物科技股份有限公司 一种用于抑制瘢痕的水凝胶及其制备方法和应用
CN116602265B (zh) * 2023-05-25 2024-05-14 北京工业大学 一种用于建立瘢痕疙瘩动物模型的智能控制系统及方法
CN117679393A (zh) * 2023-12-04 2024-03-12 中山大学附属第一医院 一种负载维替泊芬治疗增生性瘢痕的生物粘性纳米缓释颗粒
US20260115352A1 (en) 2024-10-28 2026-04-30 Cilag Gmbh International Verteporfin Containing Silicone Topical Skin Adhesive for Wound Closure and Reduced Scarring

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140086867A1 (en) * 2012-09-24 2014-03-27 Robert G. Matheny Systems, Compositions and Methods for the Treatment of Alopecia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060140984A1 (en) * 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
GB0823265D0 (en) * 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
DE102010009572A1 (de) * 2010-02-26 2011-09-01 Euroderm Gmbh Verfahren zum Begünstigen der Heilung von Hautwunden unter Verwendung der Zellen der Haarwurzelscheide, Präparat und Herstellverfahren
JP2014500275A (ja) * 2010-12-06 2014-01-09 フォリカ，インコーポレイテッド 禿頭症を治療するため、および毛髪の成長を促進するための方法
US9655967B2 (en) * 2011-12-09 2017-05-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of focal adhesion kinase for control of scar tissue formation
KR101385196B1 (ko) * 2012-05-17 2014-04-14 주식회사 유니크메디케어 광 조사를 이용한 광감각제―펩타이드를 유효성분으로 포함하는 발모 개선 또는 촉진용 조성물 및 이를 이용한 방법
US20150157584A1 (en) * 2012-06-11 2015-06-11 The J. David Gladstone Institutes Inhibitors of hippo-yap signaling pathway
IL248468A0 (en) * 2016-10-13 2017-01-31 Technion Res & Dev Foundation Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140086867A1 (en) * 2012-09-24 2014-03-27 Robert G. Matheny Systems, Compositions and Methods for the Treatment of Alopecia

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FEBS OPEN BIO, vol. 5, JPN6024026321, 2015, pages 542 - 549, ISSN: 0005681659 *
MASCHARAK, SHAMIK, ET AL.: "Inhibition of Mechanotransduciton Yields Regenerative Wound Healing by Engrailed1-negative Fibroblas", PLASTIC SURGERY RESEARCH COUNCIL. 64TH ANNUAL MEETING, vol. [retrieved on 2024-04-01], JPN6024026323, 2 May 2019 (2019-05-02), pages Retrieved from the Internet, ISSN: 0005681658 *

Also Published As

Publication number Publication date
AU2020320171B2 (en) 2025-05-29
IL289923A (en) 2022-03-01
BR112022001196A2 (pt) 2022-03-15
US20220313658A1 (en) 2022-10-06
KR20220041154A (ko) 2022-03-31
EP4003334A2 (en) 2022-06-01
CA3144185A1 (en) 2021-02-04
CN114401718A (zh) 2022-04-26
AU2020320171A1 (en) 2022-02-17
WO2021021607A3 (en) 2021-04-08
EP4003334A4 (en) 2023-08-16
WO2021021607A2 (en) 2021-02-04

Similar Documents

Publication Publication Date Title
AU2020320171B2 (en) YAP inhibition for wound healing
JP2013529919A (ja) 毛包新生
AU2014281515B2 (en) Compositions and methods for treating skin
Hsu et al. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation
Bellei et al. Regenerative medicine-based treatment for vitiligo: an overview
US20240279609A1 (en) Method for isolating human dermal fibroblasts
Shi et al. Experimental study and clinical observations of autologous hair follicle cell transplants to treat stable vitiligo
Gong et al. Protective mechanism of adipose-derived stem cells in remodelling of the skin stem cell niche during photoaging
Tresoldi et al. The role of autologous dermal micrografts in regenerative surgery: a clinical experimental study
Zhou et al. Pathogenesis and regenerative therapy in vitiligo and alopecia areata: Focus on hair follicle
Fang et al. Improvement of skin wound healing for diabetic mice with thermosensitive hydrogel combined with insulin injection
Giri et al. Therapeutic potential of endogenous stem cells and cellular factors for scar-free skin regeneration
EP3993764A1 (en) Method for preventing hair loss
Kee et al. Umbilical cord mesenchymal stromal cell-derived small extracellular vesicles modulate skin matrix synthesis and pigmentation
Shahbazi et al. The story of melanocyte: a long way from bench to bedside
TWI614031B (zh) 防止皮膚老化相關症狀的醫藥組合物及其使用方法
Chakraborty et al. Stem-cell therapy in dermatology–Challenges and opportunities
CN107982536A (zh) 一种药物作用靶点的组合物和应用
Aoi et al. Clinically applicable transplantation procedure of dermal papilla cells for hair follicle regeneration
Bai et al. ACE2 Inhibits Dermal Regeneration Through Ang II in Tissue Expansion
HK40071204A (en) Yap inhibition for wound healing
US20250195474A1 (en) Piezo Inhibition for Wound Healing
Alvarez-Viejo et al. Plasma-based scaffold containing bone-marrow mononuclear cells promotes wound healing in a mouse model of pressure injury
WO2023215294A1 (en) Complement pathway inhibition for wound healing
Mohammed et al. Biological skin regeneration using epigenetic targets

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230720

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240704

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20241003

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250418